Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib-Reference-Cited by-同舟云学术

Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib

Published:2020-10 Issue: Volume:491 Page:87-96
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhu Shoumin,Khalafi Shayan^ORCID,Chen Zheng^ORCID,Poveda Julio,Peng Dunfa,Lu Heng,Soutto Mohammed,Que Jianwen,Garcia-Buitrago Monica,Zaika Alexander,El-Rifai Wael^ORCID

Funder

Research Career Scientist award

U.S. Department of Veterans Affairs

U.S. National Institutes of Health

Sylvester Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Detection of gastric cancer with novel methylated DNA markers: discovery, tissue validation, and pilot testing in plasma;Anderson;Clin. Canc. Res.,2018

2. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer;Augoff;Mol. Canc.,2012

3. Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas;Belkhiri;Canc. Res.,2005

4. Resistance to TRAIL is mediated by DARPP-32 in gastric cancer;Belkhiri;Clin. Canc. Res.,2012

5. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer;Chan;Cochrane Database Syst. Rev.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MSH-DTI: multi-graph convolution with self-supervised embedding and heterogeneous aggregation for drug-target interaction prediction;BMC Bioinformatics;2024-08-23

2. MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application;Pharmacological Research;2024-07

3. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment;Journal of Hematology & Oncology;2024-01-17

4. ELOA promotes tumor growth and metastasis by activating RBP1 in gastric cancer;Cancer Medicine;2023-09

5. DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma;Oncogene;2021-10-21